← FDA DRUG APPROVALS

FDA ANDA · ANDA074586

M-ZOLE 7 DUAL PACK

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA074586
TYPE
ANDA
ORIGINAL APPROVAL
1997-07-17
LATEST ACTION
2002-11-21
ROUTE
TOPICAL, VAGINAL
DOSAGE FORM
CREAM, SUPPOSITORY
MARKETING STATUS
Discontinued

Products

M-ZOLE 7 DUAL PACKDiscontinued
MICONAZOLE NITRATE 2%,100MG · CREAM, SUPPOSITORY · TOPICAL, VAGINAL

Approval history

2002-11-21Labeling · Supplement 6AP
2002-01-08Manufacturing (CMC) · Supplement 5AP
2000-12-29Manufacturing (CMC) · Supplement 4AP
2000-02-09Labeling · Supplement 3AP
1999-04-30Manufacturing (CMC) · Supplement 2AP
1998-10-01Labeling · Supplement 1AP
1997-07-17OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →